X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-10-02 | PEN | Penumbra Inc | Grewal Harpreet | Dir | S - Sale | $248.61 | -186 | 8,702 | -2% | -$46,241 | ||||||
2025-10-01 | PEN | Penumbra Inc | Roberts Johanna | EVP, Gen. Counsel, Secretary | S - Sale | $249.70 | -600 | 64,257 | -1% | -$149,820 | ||||||
2025-10-01 | PEN | Penumbra Inc | Wilder Thomas | Dir | S - Sale | $253.93 | -186 | 4,692 | -4% | -$47,231 | ||||||
2025-10-01 | ATEC | Alphatec Holdings, Inc. | Miles Patrick | CEO | S - Sale | $13.96 | -100,000 | 5,724,978 | -2% | -$1,396,000 | ||||||
2025-10-02 | SGHT | Sight Sciences, Inc. | Bauerlein Alison | CFO | S - Sale | $3.30 | -19,948 | 597,520 | -3% | -$65,828 | ||||||
2025-10-01 | SGHT | Sight Sciences, Inc. | Badawi Paul | Pres, CEO, 10% | S - Sale | $3.34 | -24,441 | 5,962,502 | 0% | -$81,633 | ||||||
2025-10-03 | SGHT | Sight Sciences, Inc. | Badawi David | CTO | S - Sale | $3.27 | -6,033 | 1,864,992 | 0% | -$19,728 | ||||||
2025-10-03 | SGHT | Sight Sciences, Inc. | Hayden Jeremy B. | GC | S - Sale | $3.27 | -9,731 | 256,590 | -4% | -$31,820 | ||||||
| D | 2025-10-01 | BBNX | Beta Bionics, Inc. | Feider Stephen | CFO | S - Sale+OE | $20.76 | -15,018 | 44,041 | -25% | -$311,806 | |||||
| D | 2025-10-01 | RMD | Resmed Inc | Sandercock Brett | CFO | S - Sale+OE | $274.36 | -3,000 | 86,745 | -3% | -$823,080 | |||||
2025-10-01 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $70.19 | -5,000 | 4,572,950 | 0% | -$350,957 | ||||||
2025-10-01 | RMD | Resmed Inc | Rider Michael J | Global GC | S - Sale | $274.36 | -100 | 11,327 | -1% | -$27,436 | ||||||
2025-09-30 | HRGN | Harvard Apparatus Regenerative Technology, Inc. | He Junli | CEO | P - Purchase | $1.98 | +300 | 277,575 | 0% | +$594 | ||||||
| D | 2025-10-01 | BSX | Boston Scientific Corp | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale+OE | $98.47 | -50,000 | 183,576 | -21% | -$4,923,327 | |||||
2025-09-29 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.82 | +5,000 | 16,510,425 | 0% | +$4,101 | ||||||
2025-09-25 | NXGL | Nexgel, Inc. | Henry Scott Robert | Dir | S - Sale | $2.36 | -7,697 | 121,356 | -6% | -$18,149 | ||||||
2025-09-26 | BDX | Becton Dickinson & Co | Feld Michael | EVP, Pres, Life Sciences | S - Sale | $181.03 | -58 | 8,302 | -1% | -$10,500 | ||||||
2025-09-24 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.80 | +17,500 | 16,505,425 | 0% | +$14,035 | ||||||
2025-09-22 | GKOS | Glaukos Corp | Navratil Tomas | CHIEF DEVELOPMENT OFFICER | S - Sale | $84.22 | -517 | 75,907 | -1% | -$43,541 | ||||||
2025-09-23 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $71.26 | -5,000 | 4,577,950 | 0% | -$356,291 | ||||||
2025-09-02 | HRGN | Harvard Apparatus Regenerative Technology, Inc. | He Junli | CEO | P - Purchase | $1.85 | +11,225 | 277,275 | +4% | +$20,766 | ||||||
2025-09-23 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.82 | +2,500 | 16,487,925 | 0% | +$2,038 | ||||||
| DM | 2025-09-18 | PLSE | Pulse Biosciences, Inc. | Danahy Kevin Patrick | Chief Commercial Officer | S - Sale+OE | $18.49 | -20,400 | 43,298 | -32% | -$377,192 | |||||
| M | 2025-09-18 | ATEC | Alphatec Holdings, Inc. | Sponsel David | EVP, Sales | S - Sale | $15.09 | -140,000 | 531,861 | -21% | -$2,113,239 | |||||
2025-09-19 | OBIO | Orchestra Biomed Holdings, Inc. | Aryeh Jason | Dir | P - Purchase | $2.45 | +1,000 | 108,482 | +1% | +$2,450 | ||||||
| DM | 2025-09-16 | PLSE | Pulse Biosciences, Inc. | Uecker Darrin | CTO | S - Sale+OE | $16.25 | -45,000 | 284,406 | -14% | -$731,200 | |||||
2025-09-17 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $71.27 | -5,000 | 4,582,950 | 0% | -$356,367 | ||||||
2025-09-15 | NVNO | Envveno Medical Corp | Duhay Francis | Dir | S - Sale | $0.83 | -4,900 | 97,444 | -5% | -$4,067 | ||||||
2025-09-15 | GMED | Globus Medical Inc | Rhoads Ann D | Dir | S - Sale | $58.46 | -10,000 | 25,384 | -28% | -$584,600 | ||||||
2025-09-12 | ATRC | Atricure, Inc. | Noznesky Justin J | Chief Mktg, Strategy Officer | S - Sale | $36.30 | -3,000 | 83,964 | -3% | -$108,900 | ||||||
| DM | 2025-09-11 | PLSE | Pulse Biosciences, Inc. | Uecker Darrin | CTO | S - Sale+OE | $14.96 | -75,000 | 122,872 | -38% | -$1,121,750 | |||||
| A | 2025-03-07 | KMTS | Kestra Medical Technologies, Ltd. | Ford Alfred J Jr | Chief Commercial Officer | P - Purchase | $17.00 | +20,000 | 49,412 | +68% | +$340,000 | |||||
| D | 2025-09-12 | SI | Shoulder Innovations, Inc. | Points Jeffrey S. | CFO | P - Purchase | $15.67 | +1,600 | 52,495 | +3% | +$25,072 | |||||
| A | 2025-03-07 | KMTS | Kestra Medical Technologies, Ltd. | Umberger Traci S | See Remarks | P - Purchase | $17.00 | +13,500 | 134,336 | +11% | +$229,500 | |||||
| M | 2025-09-11 | SI | Shoulder Innovations, Inc. | Ball Robert Joseph | CEO, Exec COB | P - Purchase | $15.34 | +8,000 | 111,259 | +8% | +$122,755 | |||||
2025-09-11 | GKOS | Glaukos Corp | Navratil Tomas | CHIEF DEVELOPMENT OFFICER | S - Sale | $88.22 | -5,142 | 75,469 | -6% | -$453,620 | ||||||
| M | 2025-09-10 | PLSE | Pulse Biosciences, Inc. | Duggan Robert W | Dir, 10% | P - Purchase | $14.48 | +192,599 | 48,789,438 | 0% | +$2,788,624 | |||||
2025-09-09 | ATEC | Alphatec Holdings, Inc. | Berkowitz Mortimer III | Dir | S - Sale | $15.97 | -62,500 | 1,229,152 | -5% | -$998,125 | ||||||
2025-09-10 | BDX | Becton Dickinson & Co | Fraser Claire | Dir | S - Sale | $187.50 | -917 | 22,226 | -4% | -$171,938 | ||||||
2025-09-08 | PODD | Insulet Corp | Singh Prem | SVP, Global Operations | S - Sale | $347.49 | -687 | 3,456 | -17% | -$238,726 | ||||||
2025-09-05 | DXCM | Dexcom Inc | Malady Kyle | Dir | S - Sale | $80.86 | -667 | 22,667 | -3% | -$53,934 | ||||||
| D | 2025-09-08 | PODD | Insulet Corp | Cousin Laetitia | SVP, Reg, Quality, Compliance | S - Sale+OE | $348.81 | -797 | 3,890 | -17% | -$278,002 | |||||
2025-09-05 | NMTC | Neuroone Medical Technologies Corp | Christianson Mark | Business Development Dir | S - Sale | $0.74 | -30,000 | 231,238 | -11% | -$22,203 | ||||||
| D | 2025-09-08 | BBNX | Beta Bionics, Inc. | Feider Stephen | CFO | S - Sale+OE | $21.13 | -9,900 | 44,041 | -18% | -$209,151 | |||||
| D | 2025-09-08 | RMD | Resmed Inc | Farrell Michael J. | CEO | S - Sale+OE | $278.14 | -8,009 | 469,882 | -2% | -$2,227,590 | |||||
| DM | 2025-09-04 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Officer | S - Sale+OE | $20.34 | -18,229 | 31,215 | -37% | -$370,837 | |||||
| D | 2025-09-05 | BBNX | Beta Bionics, Inc. | Feider Stephen | CFO | S - Sale+OE | $21.00 | -100 | 44,041 | 0% | -$2,100 | |||||
2025-03-07 | KMTS | Kestra Medical Technologies, Ltd. | Cohen Raymond W | Dir | P - Purchase | $17.00 | +17,000 | 40,903 | +71% | +$289,000 | ||||||
2025-09-04 | DXCM | Dexcom Inc | Stern Sadie | EVP, CHRO | S - Sale | $80.00 | -1,466 | 105,223 | -1% | -$117,280 | ||||||
2025-09-05 | UFPT | Ufp Technologies Inc | Croteau Daniel C | Dir | S - Sale | $206.02 | -2,873 | 855 | -77% | -$591,883 | ||||||
2025-09-05 | NVCR | Novocure Ltd | Cordova Ashley | CEO | P - Purchase | $12.22 | +81,550 | 437,569 | +23% | +$996,859 | ||||||
2025-09-02 | PEN | Penumbra Inc | Grewal Harpreet | Dir | S - Sale | $272.19 | -186 | 8,888 | -2% | -$50,627 | ||||||
| D | 2025-09-03 | PEN | Penumbra Inc | Elsesser Adam | CEO | S - Sale+OE | $269.65 | -15,800 | 760,042 | -2% | -$4,260,457 | |||||
2025-09-02 | PEN | Penumbra Inc | Roberts Johanna | EVP, Gen. Counsel, Secretary | S - Sale | $270.58 | -600 | 64,857 | -1% | -$162,347 | ||||||
2025-09-02 | ATEC | Alphatec Holdings, Inc. | Miles Patrick | CEO | S - Sale | $15.73 | -300,000 | 5,824,978 | -5% | -$4,719,000 | ||||||
2025-09-02 | BBNX | Beta Bionics, Inc. | Saint Sean | Pres, CEO | S - Sale | $18.86 | -3,359 | 101,202 | -3% | -$63,361 | ||||||
2025-09-02 | BBNX | Beta Bionics, Inc. | Russell Steven Jon | Chief Medical Officer | S - Sale | $18.86 | -1,015 | 71,017 | -1% | -$19,146 | ||||||
2025-09-02 | BBNX | Beta Bionics, Inc. | Mensinger Mike | Chief Product Officer | S - Sale | $18.86 | -1,089 | 91,815 | -1% | -$20,542 | ||||||
2025-09-02 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Officer | S - Sale | $18.86 | -848 | 33,284 | -2% | -$15,996 | ||||||
2025-09-02 | BBNX | Beta Bionics, Inc. | Feider Stephen | CFO | S - Sale | $18.86 | -1,462 | 44,041 | -3% | -$27,578 | ||||||
2025-09-03 | IRTC | Irhythm Technologies, Inc. | Wilson Daniel G. | CFO | S - Sale | $175.00 | -5,000 | 34,570 | -13% | -$875,000 | ||||||
2025-09-02 | DXCM | Dexcom Inc | Sylvain Jereme M | EVP, Chief Financal Officer | S - Sale | $74.17 | -4,824 | 118,657 | -4% | -$357,796 | ||||||
2025-09-03 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.78 | +3,000 | 16,485,425 | 0% | +$2,346 | ||||||
| D | 2025-09-02 | RMD | Resmed Inc | Sandercock Brett | CFO | S - Sale+OE | $270.77 | -3,000 | 87,745 | -3% | -$812,310 | |||||
2025-09-02 | LUNG | Pulmonx Corp | Williamson Steven S. | Pres, CEO | S - Sale | $1.60 | -9,648 | 358,967 | -3% | -$15,437 | ||||||
2025-09-02 | LUNG | Pulmonx Corp | Joshi Mehul | CFO, PAO | S - Sale | $1.60 | -7,936 | 208,489 | -4% | -$12,698 | ||||||
2025-09-02 | LUNG | Pulmonx Corp | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $1.60 | -6,543 | 379,788 | -2% | -$10,469 | ||||||
2025-09-02 | LUNG | Pulmonx Corp | Lehman David Aaron | GC | S - Sale | $1.60 | -9,769 | 263,270 | -4% | -$15,630 | ||||||
2025-09-02 | IRTC | Irhythm Technologies, Inc. | Wilson Daniel G. | CFO | S - Sale | $167.28 | -737 | 39,570 | -2% | -$123,285 | ||||||
| D | 2025-09-02 | BSX | Boston Scientific Corp | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale+OE | $105.43 | -50,000 | 183,576 | -21% | -$5,271,416 | |||||
2025-09-02 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.80 | +5,500 | 16,482,425 | 0% | +$4,417 | ||||||
2025-08-29 | INSP | Inspire Medical Systems, Inc. | Buchholz Richard | CFO | S - Sale | $93.39 | -11,000 | 50,767 | -18% | -$1,027,290 | ||||||
2025-08-21 | HRGN | Harvard Apparatus Regenerative Technology, Inc. | He Junli | CEO | P - Purchase | $1.72 | +4,050 | 266,050 | +2% | +$6,966 | ||||||
2025-08-28 | NXGL | Nexgel, Inc. | Levy Adam R. | CEO | S - Sale | $2.47 | -4,000 | 358,284 | -1% | -$9,896 | ||||||
2025-08-28 | RCEL | Avita Medical, Inc. | McNamara Robert | Dir | P - Purchase | $4.50 | +10,000 | 86,771 | +13% | +$45,000 | ||||||
2025-08-27 | STSS | Sharps Technology Inc. | Ruemler Timothy James | Dir | S - Sale | $16.74 | -20,000 | 20,218 | -50% | -$334,786 | ||||||
| D | 2025-08-27 | AORT | Artivion, Inc. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale+OE | $44.02 | -18,200 | 64,200 | -22% | -$801,219 | |||||
| M | 2025-08-26 | ICU | Seastar Medical Holding Corp | Van Heel Kenneth | Dir | P - Purchase | $0.88 | +35,000 | 49,400 | +243% | +$30,813 | |||||
2025-08-27 | ICUI | Icu Medical Inc/De | Greenberg David C. | Dir | P - Purchase | $126.42 | +1,200 | 8,460 | +17% | +$151,698 | ||||||
2025-08-25 | SYK | Stryker Corp | Menon Viju | Group Pres | S - Sale | $390.61 | -500 | 12,708 | -4% | -$195,305 | ||||||
2025-08-27 | DRIO | Dariohealth Corp. | Nelson Steven Charles | Pres, CCO | P - Purchase | $0.53 | +40,000 | 95,000 | +73% | +$21,200 | ||||||
2025-08-26 | SINT | Sintx Technologies, Inc. | Moyes Jay M | Dir | P - Purchase | $3.59 | +3,000 | 3,000 | New | +$10,756 | ||||||
2025-08-26 | SINT | Sintx Technologies, Inc. | Honigblum Gregg R. | Chief Investment Officer | P - Purchase | $3.70 | +50,000 | 64,000 | +357% | +$185,000 | ||||||
| D | 2025-08-25 | STSS | Sharps Technology Inc. | Ruemler Timothy James | Dir | P - Purchase | $11.36 | +40,000 | 40,218 | >999% | +$454,301 | |||||
2025-08-22 | STSS | Sharps Technology Inc. | Monroe Jason L. | Dir | P - Purchase | $6.41 | +80,000 | 80,000 | New | +$512,800 | ||||||
2025-08-22 | STSS | Sharps Technology Inc. | Crescenzo Andrew R. | CFO | P - Purchase | $6.41 | +40,000 | 40,000 | New | +$256,400 | ||||||
2025-08-22 | STSS | Sharps Technology Inc. | Hayes Robert Michael | Dir | P - Purchase | $6.41 | +100,000 | 100,000 | New | +$641,000 | ||||||
2025-08-22 | STSS | Sharps Technology Inc. | Christiansen Soren Bo | Dir | P - Purchase | $6.41 | +80,000 | 80,000 | New | +$512,800 | ||||||
2025-08-22 | STSS | Sharps Technology Inc. | Danner Paul K | Dir | P - Purchase | $6.41 | +400,000 | 400,000 | New | +$2,564,000 | ||||||
2025-08-22 | STSS | Sharps Technology Inc. | Simpson Brenda Baird | Dir | P - Purchase | $6.41 | +20,000 | 20,000 | New | +$128,200 | ||||||
2025-08-26 | RCEL | Avita Medical, Inc. | O'Toole David D | CFO | P - Purchase | $4.52 | +2,000 | 31,657 | +7% | +$9,040 | ||||||
| D | 2025-08-22 | BBNX | Beta Bionics, Inc. | Feider Stephen | CFO | S - Sale+OE | $17.01 | -4,413 | 45,503 | -9% | -$75,083 | |||||
2025-08-22 | BDX | Becton Dickinson & Co | Feld Michael | EVP, Pres, Life Sciences | S - Sale | $197.99 | -57 | 8,360 | -1% | -$11,285 | ||||||
| D | 2025-08-25 | AORT | Artivion, Inc. | Holloway Jean F | SVP, GC | S - Sale+OE | $44.37 | -10,000 | 172,129 | -5% | -$443,700 | |||||
| D | 2025-08-22 | ATRC | Atricure, Inc. | Wehrwein Sven | Dir | S - Sale+OE | $37.00 | -5,000 | 34,374 | -13% | -$185,000 | |||||
2025-08-25 | OBIO | Orchestra Biomed Holdings, Inc. | Fain Eric S | Dir | P - Purchase | $2.61 | +5,760 | 71,709 | +9% | +$15,034 | ||||||
2025-08-25 | OBIO | Orchestra Biomed Holdings, Inc. | Sherman Darren | See Remarks | P - Purchase | $2.62 | +3,000 | 926,837 | 0% | +$7,860 | ||||||
2025-08-21 | OBIO | Orchestra Biomed Holdings, Inc. | Hochman David P | See Remarks | P - Purchase | $2.49 | +6,000 | 1,109,931 | +1% | +$14,940 | ||||||
2025-08-25 | OBIO | Orchestra Biomed Holdings, Inc. | Taylor Andrew Lawrence | CFO | P - Purchase | $2.55 | +2,000 | 482,788 | 0% | +$5,100 | ||||||
2025-08-22 | ICU | Seastar Medical Holding Corp | Chung Kevin | Chief Medical Officer | P - Purchase | $0.80 | +10,000 | 58,184 | +21% | +$8,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |